Literature DB >> 14960890

Cerebral lipidoses in patients with progressive neurodegeneration: a study from south India.

R Christopher1, A Nalini.   

Abstract

OBJECTIVE: To study the prevalence and clinical profile of cerebral lipidoses in patients with progressive neurodegeneration. SUBJECTS AND METHODS: A total of 771 patients clinically diagnosed with a progressive neurodegenerative disease were investigated for lipidoses. Specific enzyme assays in serum and leucocytes and other relevant investigations, including histopathology, neuroimaging and neurophysiological studies were conducted when indicated.
RESULTS: Fifty-four cases of sphingolipidoses and 1 case of sialidosis type 1 were diagnosed. The sphingolipidoses consisted of 30 cases of metachromatic leukodystrophy, 13 cases of Tay-Sachs disease and its variants, 11 cases of Sandhoff disease, and 1 case each of Niemann-Pick disease and multiple sulphatase deficiency. The clinical features were similar to earlier reports. Parental consanguinity was present in 63.6% of patients.
CONCLUSIONS: In south India, where consanguineous marriages are strongly favoured, inherited diseases such as the cerebral lipidoses should be considered when evaluating a patient with progressive neurodegeneration. The establishment of specialised referral centres would provide a helpful approach to the prevention and management of these fatal disorders.

Entities:  

Year:  2002        PMID: 14960890     DOI: 10.1159/000066339

Source DB:  PubMed          Journal:  Community Genet        ISSN: 1422-2795


  2 in total

1.  Status of Newborn Screening and Inborn Errors of Metabolism in India.

Authors:  Seema Kapoor; B K Thelma
Journal:  Indian J Pediatr       Date:  2018-05-07       Impact factor: 1.967

2.  Genetic counseling and prenatal diagnosis in India--experience at Sir Ganga Ram Hospital.

Authors:  I C Verma; Renu Saxena; Meena Lall; Sunita Bijarnia; Rajesh Sharma
Journal:  Indian J Pediatr       Date:  2003-04       Impact factor: 1.967

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.